Friday, November 28, 2025
HomeNews

News

Arthrosi Completes AR882 Phase 2B Study Enrollment

Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, announced the completion of enrollment for its global Phase 2b clinical study of AR882 for the treatment...

Smart Eye Deputy CEO Dr. Rana el Kaliouby to Deliver Keynote on Humanizing

Smart Eye, the global leader in Human Insight AI, announced that Deputy CEO Dr. Rana el Kaliouby will deliver a keynote address at InCabin,...

Roche’s VENTANA PD-L1 test gains CE Label Expansion

Roche announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC) as a companion diagnostic for Tecentriq® (atezolizumab)....

Gatik and Cummins Integrate Gatik’s Autonomous Driving Technology

Gatik announced that it will collaborate with Cummins Inc. to facilitate the integration of Gatik's autonomous driving system with Cummins’ advanced powertrain solution in...

Tegra Medical Expands Costa Rica Manufacturing Operations With New Building

Tegra Medical, a leading contract manufacturer of medical devices and a member of SFS, which is headquartered in Heerbrugg Switzerland, announced it is expanding...
0FansLike
0FollowersFollow
spot_img

Hot Topics